key: cord-0879713-5kreox6e authors: Beltempo, Pasquale; Curti, Serena Maria; Maserati, Renato; Gherardi, Mirella; Castelli, Maurizio title: Persistence of SARS-CoV-2 RNA In Post-Mortem Swab 35 days after Death: a case report date: 2020-12-09 journal: Forensic Sci Int DOI: 10.1016/j.forsciint.2020.110653 sha: 0dcb0418ab8814fdcc565ac4ab57eda814dbf334 doc_id: 879713 cord_uid: 5kreox6e Post-mortem swabs for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA detection have been recommended by several Scientific Committees and Institutions as a standard procedure for post-mortem assessment of potential Coronavirus Disease-19 (COVID-19) related deaths. To date there is no data about the SARS-CoV-2 RNA detectability period in human bodies after death. The present case documents the persistence of SARS-CoV-2 RNA in the upper respiratory tract 35-days after death. Post-mortem swabs could be used as a valuable tool in preventive evaluation of the risks-benefits ratio associated with autopsy execution. SARS-CoV-2 RNA post-mortem detection could have a key diagnostic role in deaths lacking medical assistance, unattended deaths, and patients with multiple comorbidities. Based on the present report, staged post-mortem swabs should be performed even after a long post-mortem interval. Since December 2019 until today, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has caused more than 1300000 deaths worldwide (1). The diagnosis of acute infection is carried out in the vast majority of cases through the search of the viral ribonucleic acid (RNA) on respiratory specimens, primarily by means of the rhino-or oropharyngeal swabs. In living people, respiratory droplets and interpersonal physical contacts are known to be the main routes of transmission, while conjunctival and bronchial epithelium are considered portals for infection (2) . However, human coronaviruses have been shown to persist on inanimate surfaces up to 9 days (3). Generally, a large amount of viruses may remain in deceased people and be detected by polymerase-chainreaction (PCR) amplification (4). There is no evidence of correlation between amplifiable SARS-CoV-2 RNA detected in respiratory swabs and infectious risk. Till now, none of the alleged cases of Coronavirus Disease-19 (COVID-19) transmission from a corpse has been confirmed (5). However, being impossible at present to exclude the risk of contagion from corpse to forensic pathologists, technicians, and mortuary workers, international guidelines stress the use of biosafety level (BSL) 3 protection standards in case of suspected or confirmed COVID 2019 cadavers examination (6). We hereby report persistence of SARS-CoV-2 RNA in post-mortem rhino-and oropharyngeal swabs from a COVID 2019 35-days after death. On 15th March 2020 a 60-year-old man, with an history of Obstructive Sleep Apnea Syndrome (OSAS) in former tobacco smoking, Steinert myotonic dystrophy, pace maker implantation for ischemic cardiomyopathy with left bundle branch block, and diabetes, was brought to the regional hospital of Aosta (Italy) after accidental fall at home. On admission, temperature was 37.5°C and oxygen saturation 90%. Chest radiograph showed band shadows in lower left lobe [ Fig.1 ]. Blood routine test showed leucocytopenia. Respiratory tract swabs were sent to laboratory. SARS-CoV-2 infection was confirmed by Reverse Transcriptase Polymerase-Chain-Reaction Real Time (RT PCR-RT) on 16th March 2020. The patient was therefore transferred to a COVID 2019 Unit and Non Invasive Mechanical Ventilation (NIMV) was started due to recurring desaturation crisis. Respiratory symptoms worsened during the night. Despite NIMV and vital support therapy, the patient died on 17th March 2020. SARS-CoV-2 pneumonia was reported as primary cause of death, while Steinert myotonic dystrophy, and ischemic cardiomyopathy were listed as contributory. His body was transported to the local crematorium and placed in a refrigerator (-4°C), pending the wife's authorization for cremation (required by the Italian Law). Indeed, during the same time period, the patient wife had also been admitted in a COVID Unit of the same hospital with severe respiratory symptoms. After treatment with antiviral therapy, respiratory symptoms had improved. On April 13th, after two consecutive tests for SARS-CoV-2 RNA resulted negative, the woman had been transferred in a non-COVID unit. She therefore gave authorization for incineration of the husband cadaver. Due to local crematorium technical specifications, removal of pace maker device was required. WHO, World Health Organization. Coronavirus Disease Situation Report -118 Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Investigation of viral respiratory tract infection agents by multiplex PCR method in autopsy cases: A fiveyear study COVID-19 in forensic medicine unit personnel: Observation from Thailand Autopsy in suspected COVID-19 cases Diagnostic detection of 2019-nCoV by real-time RT-PCR Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive Postmortem Swabs in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: Report on 12 Complete Clinical Autopsy Cases Guide to forensic pathology practice for death cases related to coronavirus disease 2019 (COVID-19) (Trial draft). Mao, D, et al. 1, s.l. : Jianding Cheng Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection -Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures, during autopsy practice. Fineschi Arrangement international concernant le transport des corps The autopsy debate during the COVID-19 emergency: the Italian experience